Future Of Cancer Treatment: Immunotherapy Startups Take Lion’s Share of Oncology Deals https://t.co/h9Eip0JN9h — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
Here’s who Goldman Sachs thinks you should pay attention to in tech this year – Recode https://t.co/IIHXPsH1EH — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
Celgene, Novartis, Pfizer, Google Back Startups Attacking Cancer https://t.co/75dGXcKl6S — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
The Economist | Private Equity: The barbarian establishment https://t.co/CIZp4GzTHe — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
The Economist | Business in America: Float like a butterfly https://t.co/va0wmG80by — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
Microsoft says it will solve cancer in the next 10 years https://t.co/n38zPJLZmJ — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
Making the microbiome part of precision medicine https://t.co/83cYFGo5wF — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
Putting a legal spotlight on labs that are tweaking evolution with CRISPR https://t.co/wdAoRZ5Yud — The Propell Group (@ThePropellGroup) November 5, 2016 #healthtech
In-Depth: With Diabetes Prevention Programs, digital programs are close to earning CMS’s approval | MobiHealthNews https://t.co/vNpnbJY5t8 — The Propell Group (@ThePropellGroup) November 5, [...]
Growing anti-malaria drugs in tobacco plants https://t.co/ssQ9Qx7Urv — The Propell Group (@ThePropellGroup) November 5, 2016 #healthtech